Compositions and Methods for Treating or Preventing Lupus Read more about Compositions and Methods for Treating or Preventing Lupus US Patent 10,017,762Filed on 2017-04-26
ENGINEERING NEURAL STEM CELLS USING HOMOLOGOUS RECOMBINATION Read more about ENGINEERING NEURAL STEM CELLS USING HOMOLOGOUS RECOMBINATION Canada2930590Filed on 2014-11-14
Engineering Neural Stem Cells using Homologous Recombination Read more about Engineering Neural Stem Cells using Homologous Recombination US Patent 9,951,353Filed on 2016-05-11
Cross-linked Polymer Matrices, And Methods Of Making And Using Same Read more about Cross-linked Polymer Matrices, And Methods Of Making And Using Same US Application 14/215,270Filed on 2014-03-17
Cross-linked Polymer Matrices, And Methods Of Making And Using Same Read more about Cross-linked Polymer Matrices, And Methods Of Making And Using Same Japan2011-003497Filed on 2003-09-25
Antibodies the Bind to TL1A and Methods of Treating Inflammatory or Autoimmune Disease Comprising Administering Such Antibodies Read more about Antibodies the Bind to TL1A and Methods of Treating Inflammatory or Autoimmune Disease Comprising Administering Such Antibodies US Patent 9,896,511Filed on 2015-11-02
ANTIBODIES THAT BIND TO TL1A AND METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASE ADMINISTERING SUCH ANTIBODIES Read more about ANTIBODIES THAT BIND TO TL1A AND METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASE ADMINISTERING SUCH ANTIBODIES US Application 14/826,462Filed on 2015-08-14
REGENERATIVE TISSUE GRAFTS AND METHODS OF MAKING SAME Read more about REGENERATIVE TISSUE GRAFTS AND METHODS OF MAKING SAME US Patent 10,507,187Filed on 2014-02-12
Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side Read more about Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side US Patent 8,652,458Filed on 2009-08-05
Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology and Antibodies Thereof Read more about Blockade of TL1A-DR3 Interactions to Ameliorate T Cell Mediated Disease Pathology and Antibodies Thereof US Application 14/733,695Filed on 2015-06-08